Naproxen sodium

Available EU dossier in development

Offer available for: licensing

Pharmaceutical form and dosage: 225 mg

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Arthritis / Rheumato

Action: Anti-inflammatory and antirheumatic products - analgesics (Rheumato)

Full Description:
Naproxen sodium dossier:
-New readily available for licensing
-Available: IV/2002
-Stability: 25°C: 24 months + continued, 40°C: 6 months

Availability and Market information:

Status: Development

Market information

Other Market Info:

Patent Information:
Name: Aleve = Naprosyne
Patent info: Expired